These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 9157573)
1. HLA genotype of patients with severe haemophilia A due to intron 22 inversion with and without inhibitors of factor VIII. Oldenburg J; Picard JK; Schwaab R; Brackmann HH; Tuddenham EG; Simpson E Thromb Haemost; 1997 Feb; 77(2):238-42. PubMed ID: 9157573 [TBL] [Abstract][Full Text] [Related]
2. HLA class II profile: a weak determinant of factor VIII inhibitor development in severe haemophilia A. UKHCDO Inhibitor Working Party. Hay CR; Ollier W; Pepper L; Cumming A; Keeney S; Goodeve AC; Colvin BT; Hill FG; Preston FE; Peake IR Thromb Haemost; 1997 Feb; 77(2):234-7. PubMed ID: 9157572 [TBL] [Abstract][Full Text] [Related]
3. Risk factors for inhibitor development in hemophilia A. Oldenburg J; Brackmann HH; Schwaab R Haematologica; 2000 Oct; 85(10 Suppl):7-13; discussion 13-4. PubMed ID: 11187876 [TBL] [Abstract][Full Text] [Related]
4. Frequency of intron 1 and 22 inversions of Factor VIII gene in Mexican patients with severe hemophilia A. Mantilla-Capacho JM; Beltrán-Miranda CP; Luna-Záizar H; Aguilar-López L; Esparza-Flores MA; López-Guido B; Troyo-Sanromán R; Jaloma-Cruz AR Am J Hematol; 2007 Apr; 82(4):283-7. PubMed ID: 17211847 [TBL] [Abstract][Full Text] [Related]
5. HLA class II genotype and factor VIII inhibitors in mild haemophilia A patients with an Arg593 to Cys mutation. Bril WS; MacLean PE; Kaijen PH; van den Brink EN; Lardy NM; Fijnvandraat K; Peters M; Voorberg J Haemophilia; 2004 Sep; 10(5):509-14. PubMed ID: 15357778 [TBL] [Abstract][Full Text] [Related]
6. Correlation between factor VIII genotype and inhibitor development in hemophilia A. Fakharzadeh SS; Kazazian HH Semin Thromb Hemost; 2000; 26(2):167-71. PubMed ID: 10919409 [TBL] [Abstract][Full Text] [Related]
7. Prevalence of the intron 22 inversion of the factor VIII gene and inhibitor development in Polish patients with severe hemophilia A. Sawecka J; Skulimowska J; Windyga J; Lopaciuk S; Kościelak J Arch Immunol Ther Exp (Warsz); 2005; 53(4):352-6. PubMed ID: 16088320 [TBL] [Abstract][Full Text] [Related]
8. Inhibitor development in haemophilia A patients with inversion of the intron 22 of the factor VIII gene. Tizzano EF; Altisent C; Domènech M; Cornet M; Tusell J; Baiget M Thromb Haemost; 1996 Jul; 76(1):125-6. PubMed ID: 8819266 [No Abstract] [Full Text] [Related]
9. In silico calculated affinity of FVIII-derived peptides for HLA class II alleles predicts inhibitor development in haemophilia A patients with missense mutations in the F8 gene. Pashov AD; Calvez T; Gilardin L; Maillère B; Repessé Y; Oldenburg J; Pavlova A; Kaveri SV; Lacroix-Desmazes S Haemophilia; 2014 Mar; 20(2):176-84. PubMed ID: 24118514 [TBL] [Abstract][Full Text] [Related]
10. Influence of class I and II HLA alleles on inhibitor development in severe haemophilia A patients from the south of Brazil. De Barros MF; Herrero JC; Sell AM; De Melo FC; Braga MA; Pelissari CB; Machado J; De Souza Schiller S; De Souza Hirle L; Visentainer JE Haemophilia; 2012 May; 18(3):e236-40. PubMed ID: 21726358 [TBL] [Abstract][Full Text] [Related]
11. Introns 1 and 22 inversions and factor VIII inhibitors in patients with severe haemophilia A in southern Brazil. Leiria LB; Roisenberg I; Salzano FM; Bandinelli E Haemophilia; 2009 Jan; 15(1):309-13. PubMed ID: 18759747 [TBL] [Abstract][Full Text] [Related]
12. Factor VIII genotype and inhibitor development in patients with haemophilia A: highest risk in patients with splice site mutations. Boekhorst J; Lari GR; D'Oiron R; Costa JM; Nováková IR; Ala FA; Lavergne JM; VAN Heerde WL Haemophilia; 2008 Jul; 14(4):729-35. PubMed ID: 18503540 [TBL] [Abstract][Full Text] [Related]
13. Impact of HLA alleles and cytokine polymorphisms on inhibitors development in children with severe haemophilia A. Pergantou H; Varela I; Moraloglou O; Economou M; Spanou K; Kapsimali Z; Constantinidou N; Platokouki H Haemophilia; 2013 Sep; 19(5):706-10. PubMed ID: 23607306 [TBL] [Abstract][Full Text] [Related]
15. Inhibitor-Immunology-Study. Different HLA-types seem to be involved in the inhibitor development in haemophilia A. Wieland I; Wermes C; Eifrig B; Holstein K; Pollmann H; Siegmund B; Bidlingmaier C; Kurnik K; Nimtz-Talaska A; Niekrens C; Eisert R; Tiede A; Ebenebe C; Lakomek M; Hoy L; Welte K; Sykora KW Hamostaseologie; 2008 Oct; 28 Suppl 1():S26-8. PubMed ID: 18958335 [TBL] [Abstract][Full Text] [Related]
16. HLA class II DR and DQ genotypes and haplotypes associated with rheumatic fever among a clinically homogeneous patient population of Latvian children. Stanevicha V; Eglite J; Zavadska D; Sochnevs A; Shantere R; Gardovska D Arthritis Res Ther; 2007; 9(3):R58. PubMed ID: 17559688 [TBL] [Abstract][Full Text] [Related]
17. Relationship between factor VIII mutation type and inhibitor development in a cohort of previously untreated patients treated with recombinant factor VIII (Recombinate). Recombinate PUP Study Group. Goodeve AC; Williams I; Bray GL; Peake IR Thromb Haemost; 2000 Jun; 83(6):844-8. PubMed ID: 10896236 [TBL] [Abstract][Full Text] [Related]
18. Analysis of F8 inversions as risk factors for FVIII inhibitor development in Indian severe haemophilia A patients. Pinto P; Ghosh K; Shetty S Blood Cells Mol Dis; 2014 Sep; 53(3):161-3. PubMed ID: 24824129 [TBL] [Abstract][Full Text] [Related]
19. Haplotype-specific pattern of association of human major histocompatibility complex with non-Hodgkin's lymphoma outcome. Nowak J; Kalinka-Warzocha E; Juszczyński P; Mika-Witkowska R; Zajko M; Graczyk-Pol E; Coiffier B; Salles G; Warzocha K Tissue Antigens; 2008 Jan; 71(1):16-26. PubMed ID: 17971052 [TBL] [Abstract][Full Text] [Related]
20. Clinical correlates among 49 families with hemophilia A and factor VIII gene inversions. Weinmann AF; Schoof JM; Thompson AR Am J Hematol; 1996 Mar; 51(3):192-9. PubMed ID: 8619399 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]